Cometriq (Cabozantinib) Capsules
Description of Cometriq (Cabozantinib)
Cometriq is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body (metastatic)
Its use and Indications
Cometriq is indicated for treatment of progressive, metastatic medullary thyroid cancer. It is a Tyrosine Kinase Inhibitor.
Treatment related info
For treatment related information, please consult your treating Physician.
Cometriq capsules are supplied as printed hard gelatin capsules containing cabozantinib (S) – malate equivalent to 20 mg or 80 mg cabozantinib.
Storage and handling
Store at 20°- 25° C, excursions permitted to 15° to 30° C.
How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
M/s Exelixis Inc.
Mob No: +91 7738100125, +91 7738151650
E Mail: firstname.lastname@example.org